Biotech

TiGenix's New European Production Facility Obtains EMA Approval for Commercial Production of ChondroCelect

LEUVEN, BELGIUM: ...

Functional Technologies Reports Increase in Non-Brokered Private Placement

VANCOUVER, BRITISH COLUMBIA: ...

MethylGene Announces Change of President and CEO

MONTREAL, QUEBEC: ...

Peregrine Pharmaceuticals Announces That It Has Discovered Major Discrepancies in Treatment Group Coding by an Independent Third-Party Vendor Responsible for Distribution of Blinded Investigational Product Used in Its Bavituximab Phase II Second-Line Non-

TUSTIN, CA: The Company Is Currently Conducting a Detailed Review, Including Assessing Its Impact on Overall Trial Results; Investors Should Not Rely on Previously Reported Clinical Data Disclosed From This Phase ...

Clinical Ink Wins 2012 Data Driven Innovation Award From The Society of Clinical Data Management

WINSTON-SALEM, NC: Award Recognizes Dramatic Business Results Achieved in Novartis' First FDA-Approved eSource Study ...

Prima BioMed to Present at BIOX

SYDNEY, AUSTRALIA: ...

Critical Outcome Technologies Inc. Announces Warrant Term Amendments

LONDON, ONTARIO: ...

Critical Outcome Technologies Announces Important New Mechanism of Action Data for COTI-2

LONDON, ONTARIO: Effective in Cell Lines with Mutations in Cancer Suppressing Gene P53 ...

Agile Therapeutics to Present at CBI's Forum on Phase II-III Clinical Study Optimization

PRINCETON, NJ: Chief Medical Officer to Discuss Company's Experiences in AG200-15 Phase III Trials ...

Tonix Pharmaceuticals Highlights Therapeutic Programs on CEONEWS.Tv

NEW YORK, NY: CEO Discusses Company's Unique Approach to Treating Fibromyalgia by Improving Sleep Quality ...